A Focus on Severe Acute Respiratory Syndrome (
            <scp>SARS</scp>
            ) Coronavirus (
            <scp>SARS‐CoVs</scp>
            ) 1 and 2

Cannalire, Rolando; Tramontano, Enzo; Summa, Vincenzo

doi:10.1002/9783527810697.ch17

Cited by 1 publication

(1 citation statement)

References 116 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We do not address drug therapy for severe conditions of the infection, which is usually aimed at reversing or treating the effects of immune dysregulation and inflammation with steroids and/or anti-cytokine drugs and/or other agents. Additionally, we also refer to the comprehensive reviews discussing therapeutic aspects of COVID-19 in detail [38,116,118].…”

Section: Anti-sars-cov-2 Agentsmentioning

confidence: 99%

Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine

Kálai

Pongrácz

Mátyus³

2022

Chemistry

View full text Add to dashboard Cite

Viruses, and in particular, RNA viruses, dominate the WHO’s current list of ten global health threats. Of these, we review the widespread and most common HIV, influenza virus, and SARS-CoV-2 infections, as well as their possible prevention by vaccination and treatments by pharmacotherapeutic approaches. Beyond the vaccination, we discuss the virus-targeting and host-targeting drugs approved in the last five years, in the case of SARS-CoV-2 in the last one year, as well as new drug candidates and lead molecules that have been published in the same periods. We share our views on vaccination and pharmacotherapy, their mutually reinforcing strategic significance in combating pandemics, and the pros and cons of host and virus-targeted drug therapy. The COVID-19 pandemic has provided evidence of our limited armamentarium to fight emerging viral diseases. Novel broad-spectrum vaccines as well as drugs that could even be applied as prophylactic treatments or in early phases of the viremia, possibly through oral administration, are needed in all three areas. To meet these needs, the use of multi-data-based precision medicine in the practice and innovation of vaccination and drug therapy is inevitable.

show abstract

Section: Anti-sars-cov-2 Agentsmentioning

confidence: 99%